What smart money is saying about Mirum Pharmaceuticals
MIRM
No fund has written a full thesis on Mirum Pharmaceuticals in our archive, but 1 fund letter reports a position in it — most recently Buffalo funds High Yield Fund in June 2026.
Get an email when a fund writes about it
1
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Every position in Mirum Pharmaceuticals on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
Fund activity · 1 position
- June 2026
“Mirum Pharmaceuticals underlying common stock continued to reach new highs during the quarter, driving the company’s convertible bonds higher as well.”
Mirum Pharmaceuticals
Also mentioned · 1
These funds discuss Mirum Pharmaceuticals — as a competitor, benchmark or comparable — without disclosing a position in it.
- March 2026
“Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing novel therapies for liver disease.”
Mirum Pharmaceuticals
Read the letters behind these Mirum Pharmaceuticals positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger